243 filings
8-K
CTSO
Cytosorbents Corp
10 Jun 24
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
CTSO
Cytosorbents Corp
22 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
CTSO
Cytosorbents Corp
9 May 24
CytoSorbents Reports First Quarter 2024 Results
5:23pm
8-K
CTSO
Cytosorbents Corp
6 May 24
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
CTSO
Cytosorbents Corp
3 Apr 24
Departure of Directors or Certain Officers
6:06am
8-K
zi7k adrghbqa
14 Mar 24
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
8:55pm
8-K
fs0e8q q77
17 Jan 24
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
5:20pm
8-K
qwc g1qq3gf08nqd
28 Dec 23
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
4:49pm
8-K
8588 mfc4vqlval7
13 Dec 23
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
9:15am
8-K
tyi c52i2n43i
11 Dec 23
Entry into a Material Definitive Agreement
4:10pm
8-K
krw18
9 Nov 23
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
4:20pm
8-K
z02lk0hwwbfeg5
27 Sep 23
Other Events
8:15am
8-K
f7l17
19 Sep 23
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
4:30pm
8-K
3iyilrw t7lyx3
12 Sep 23
Other Events
4:31pm
8-K
3va4nwmyy3l
1 Sep 23
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
4:30pm
8-K
3r4 93lpr9m4e87ip2a
11 Aug 23
Regulation FD Disclosure
5:30pm
8-K
cv4h280logrlsi7a3
2 Aug 23
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
12:00am
8-K
5pxcq8dcg
19 Jul 23
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
5:19pm
8-K
ee3779kj9 r0ig
11 Jul 23
Departure of Directors or Certain Officers
5:21pm
8-K
u6mky
7 Jul 23
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
4:31pm